Ensuring the safety and quality of ATMP or cell-based therapeutics is critical for their successful translation into clinical applications. Mycoplasma contamination poses a significant risk to the safety and overall integrity of cell therapies, necessitating robust and rapid detection methods. Join us as we discuss the benefits and performance characteristics of using a PCR-based rapid testing approach to mycoplasma detection.

In this webinar you’ll learn:

• Basic principles of Mycoplasma detection in biopharma applications
• Key assay performance points of PCR-based mycoplasma detection methods
• Value of working with an engaged commercial supplier

• QC Microbiology 
• Manufacturing QC
• Biosafety Testing
• Process Development